lanosterol - CISMeF

Preferred Label : lanosterol;

MeSH definition : A triterpene that derives from the chair-boat-chair-boat folding of 2,3-oxidosqualene. It is metabolized to CHOLESTEROL and CUCURBITACINS.;

MeSH synonym : kryptosterol; 4,4,14 alpha-trimethyl-5 alpha-cholesta-8,24-dien-3 beta-ol;

MeSH CAS label : Lanosta-8,24-dien-3-ol, (3beta)-;

MeSH Related Number : 79-63-0 (Lanosterol);

Registry Number MeSH : 79-63-0;

Wikipedia link : https://en.wikipedia.org/wiki/Lanosterol;

Codes EINECS : 201-214-9;

Is substance : O;

UNII : 1J05Z83K3M;

InChIKey : CAHGCLMLTWQZNJ-BQNIITSRSA-N;

Details

Origin ID

D007810;

UMLS CUI

C0023025;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Lanosterol [LOINC component]
- Lanosterol (substance) [SNOMED CT concept]
- lanosterol [SNOMED Notion]
CISMeF manual mappings
- lanosterol [Substance BNPC]
Indexing information
- lanosterol oxidase [MeSH Supplementary Concept]
Record concept(s)
- lanosterol [MeSH concept]
Related MeSH Supplementary Concept(s)
- (23R,24S)-16,23-16,24-diepoxy-9,19-cyclolanostan-3beta,15alpha,25-triol [MeSH Supplementary Concept]
- (23S)-lanosta-8,24-diene-3 beta,23-diol [MeSH Supplementary Concept]
- (25S)-(+)-12alpha-hydroxy-3alpha-methylcarboxyacetate-24-methyllanosta-8,24(31)-diene-26-oic acid [MeSH Supplementary Concept]
- 12beta-acetoxy-3beta,7beta-dihydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid [MeSH Supplementary Concept]
- 14-methylenecyclopropyl-delat7-24,25-dihydrolanosterol [MeSH Supplementary Concept]
- 15-O-acetylganolucidate A [MeSH Supplementary Concept]
- 15-fluorolanost-7-en-3-ol [MeSH Supplementary Concept]
- 15-hydroxy-ganoderic acid S [MeSH Supplementary Concept]
- 2-hydroxy-24-methylenelanostan-1,8-dien-3-one [MeSH Supplementary Concept]
- 20-hydroxylganoderic acid G [MeSH Supplementary Concept]
- 23,24,25,26,27-pentanordihydrolanosterol [MeSH Supplementary Concept]
- 24(28)-methylene-24,25-dihydrolanosterol [MeSH Supplementary Concept]
- 24,25-iminolanosterol [MeSH Supplementary Concept]
- 24,25-oxidolanosterol [MeSH Supplementary Concept]
- 24-ethyl,24-methyl-29-nor-5alpha-lanosta-4(28),7,25-trien-3beta-ol [MeSH Supplementary Concept]
- 24-ethyl,24-methyl-29-nor-5alpha-lanosta-4(28),7-dien-3beta-ol [MeSH Supplementary Concept]
- 24-methylenelanosta-7,9(11)-diene-3,15-diol-21-oic acid [MeSH Supplementary Concept]
- 24-methylenelanosta-9(11)-en-3beta-ol [MeSH Supplementary Concept]
- 24-methyllanosta-8,24(28)-diene-3,22-diol [MeSH Supplementary Concept]
- 24-methyllanosta-8-en-22,28-epoxy-3,28-diol [MeSH Supplementary Concept]
- 25-aminolanosterol [MeSH Supplementary Concept]
- 26,27-dihydroxy-5 alpha-lanosta-7,9(11),24-triene-3,22-dione [MeSH Supplementary Concept]
- 26-hydroxy-5 alpha-lanosta-7,9(11),24-triene-3,22-dione [MeSH Supplementary Concept]
- 27-nor-24,25-dihydrolanosterol [MeSH Supplementary Concept]
- 29-hydroxypolyporenic acid C [MeSH Supplementary Concept]
- 3,4-seco-17,14-friedo-9H-lanosta-4(28),6,8(14)-trien-26,23-olid-3-oic acid [MeSH Supplementary Concept]
- 3,4-seco-8-(14-13R)abeo-17,13-friedo-9beta-lanosta-4(28),7,14,24-tetraen-26,23-olide-23-hydroxy-3-oic acid [MeSH Supplementary Concept]
- 3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic acid [MeSH Supplementary Concept]
- 3-alpha-acetylpolyporenic acid [MeSH Supplementary Concept]
- 3-hydroxy-16-acetoxylanosta-7,9(11),24-trien-21-oic acid [MeSH Supplementary Concept]
- 3-hydroxylanost-7-en-15-one [MeSH Supplementary Concept]
- 3-hydroxylanost-7-en-15-one 15-oxime [MeSH Supplementary Concept]
- 3-hydroxylanost-7-en-32-al [MeSH Supplementary Concept]
- 3-hydroxylanost-7-en-32-oic acid [MeSH Supplementary Concept]
- 3-hydroxylanosta-7,9(11),24-trien-21-oic acid [MeSH Supplementary Concept]
- 3-hydroxylanosta-7,9(11)-dien-32-al [MeSH Supplementary Concept]
- 3-hydroxylanosta-8,24-dien-26-al-21-oic acid [MeSH Supplementary Concept]
- 3-oxolanosta-9betaH-7-en-24S,25-diol [MeSH Supplementary Concept]
- 3-oxosulfurenic acid [MeSH Supplementary Concept]
- 32-hydroxy-24,25-dihydrolanosterol [MeSH Supplementary Concept]
- 32-hydroxylanosterol [MeSH Supplementary Concept]
- 32-oxolanosterol [MeSH Supplementary Concept]
- 32-vinyllanost-8-en-3,32-diol [MeSH Supplementary Concept]
- 3alpha-hydroxy-15alpha-acetoxy-lanosta-7,9(11),24-trien-26-oic acid [MeSH Supplementary Concept]
- 3beta,15beta-dihydroxy-7,11,23-trioxo-lanost-8,16-dien-26-oic acid methyl ester [MeSH Supplementary Concept]
- 3beta,23beta-dimethoxy-5alpha-lanosta-24(24(1))-ene [MeSH Supplementary Concept]
- 3beta,23beta-dimethoxycycloartan-24(24(1))-ene [MeSH Supplementary Concept]
- 3beta,7beta,15beta-trihydroxy-11,23-dioxo-lanost-8,16-dien-26-oic acid [MeSH Supplementary Concept]
- 3beta,7beta,15beta-trihydroxy-11,23-dioxo-lanost-8,16-dien-26-oic acid methyl ester [MeSH Supplementary Concept]
- 3beta,7beta-di- hydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid [MeSH Supplementary Concept]
- 3beta,7beta-dihydroxy-11,15,23-trioxo-lanost-8,16-dien-26-oic acid methyl ester [MeSH Supplementary Concept]
- 3beta-hydroxy-lanost-7-ene [MeSH Supplementary Concept]
- 3beta-hydroxylanosta-9,24-dien-21-oic acid [MeSH Supplementary Concept]
- 3beta-methoxycycloartan-24(24(1))-ene [MeSH Supplementary Concept]
- 4,4-dimethyl-delta(8)-cholestenol [MeSH Supplementary Concept]
- 5-lanosta-7,9(11),24-triene-15,26-dihydroxy-3-one [MeSH Supplementary Concept]
- 5-lanosta-7,9(11),24-triene-3-hydroxy-26-al [MeSH Supplementary Concept]
- 6-O-acyl-beta-D-glucosyl-beta-sitosterol [MeSH Supplementary Concept]
- 7-O-ethyl ganoderic acid O [MeSH Supplementary Concept]
- 7-oxo-24,25-dihydrolanosterol [MeSH Supplementary Concept]
- 7-oxo-ganoderic acid Z [MeSH Supplementary Concept]
- 8,9-dihydroganoderate J [MeSH Supplementary Concept]
- 8,9-dihydroganoderic acid J [MeSH Supplementary Concept]
- SK&F 104976 [MeSH Supplementary Concept]
- abiesanolide C [MeSH Supplementary Concept]
- agnosterol [MeSH Supplementary Concept]
- agrostophyllinone [MeSH Supplementary Concept]
- ananosic acid B [MeSH Supplementary Concept]
- ananosic acid C [MeSH Supplementary Concept]
- ascotrichic acid B [MeSH Supplementary Concept]
- bacchar-12-en-3beta-ol [MeSH Supplementary Concept]
- cimicifugoside [MeSH Supplementary Concept]
- cimifoetiside III [MeSH Supplementary Concept]
- cimifoetiside IV [MeSH Supplementary Concept]
- cimifoetiside V [MeSH Supplementary Concept]
- cladosporide A [MeSH Supplementary Concept]
- cladosporide B [MeSH Supplementary Concept]
- cladosporide C [MeSH Supplementary Concept]
- cladosporide D [MeSH Supplementary Concept]
- clavaric acid [MeSH Supplementary Concept]
- cochlate A [MeSH Supplementary Concept]
- cochlate B [MeSH Supplementary Concept]
- cucurbita-5,24-dien-3-ol [MeSH Supplementary Concept]
- dehydroeburicoic acid [MeSH Supplementary Concept]
- dihydroagnosterol [MeSH Supplementary Concept]
- ebericol [MeSH Supplementary Concept]
- eburicoic acid [MeSH Supplementary Concept]
- ethyl lucidenate A [MeSH Supplementary Concept]
- euphol [MeSH Supplementary Concept]
- fomiroid A [MeSH Supplementary Concept]
- fomitopinic acid A [MeSH Supplementary Concept]
- fomitopinic acid B [MeSH Supplementary Concept]
- ganoderic acid A [MeSH Supplementary Concept]
- ganoderic acid F [MeSH Supplementary Concept]
- ganoderic acid H [MeSH Supplementary Concept]
- ganoderic acid T [MeSH Supplementary Concept]
- ganoderic acid sz [MeSH Supplementary Concept]
- ganoderitriol M [MeSH Supplementary Concept]
- ganodermadiol [MeSH Supplementary Concept]
- ganodermanontriol [MeSH Supplementary Concept]
- ganodermatriol [MeSH Supplementary Concept]
- ganodermenonol [MeSH Supplementary Concept]
- ganodermic acid S [MeSH Supplementary Concept]
- ganosporeric acid A [MeSH Supplementary Concept]
- ganoweberianone A [MeSH Supplementary Concept]
- ganoweberianone B [MeSH Supplementary Concept]
- garcihombronane C [MeSH Supplementary Concept]
- garcihombronane D [MeSH Supplementary Concept]
- inonotsuoxide A [MeSH Supplementary Concept]
- inonotsuoxide B [MeSH Supplementary Concept]
- inotodiol [MeSH Supplementary Concept]
- isoganoweberianone A [MeSH Supplementary Concept]
- isoganoweberianone B [MeSH Supplementary Concept]
- kadsuracoccinic acid A [MeSH Supplementary Concept]
- kadsuracoccinic acid B [MeSH Supplementary Concept]
- kadsuracoccinic acid C [MeSH Supplementary Concept]
- lanost-8-en-3-ol-24-one [MeSH Supplementary Concept]
- lanostan-8,24-dien-3-ol [MeSH Supplementary Concept]
- lanostanoid [MeSH Supplementary Concept]
- lanosten-3-ol-32-al [MeSH Supplementary Concept]
- lanostenol [MeSH Supplementary Concept]
- lanosteryl acetate [MeSH Supplementary Concept]
- lanosteryl triterpene RA-3 [MeSH Supplementary Concept]
- methyl 3-hydroxylanosta-9,24-dien-21-oate [MeSH Supplementary Concept]
- methyl-3,4-seco-8-(14-3R) abeo-17,13-friedo-9beta-lanosta-4(28),7,14, 24-tetraen-26,23-olide-23-hydroxy-3-oate [MeSH Supplementary Concept]
- methyl-3,4-seco-9H-lanosta-4(28),7-dien-26,23-olid-3-oate [MeSH Supplementary Concept]
- mogrol [MeSH Supplementary Concept]
- momorcharaside A [MeSH Supplementary Concept]
- momorcharaside B [MeSH Supplementary Concept]
- oenotheralanosterol A [MeSH Supplementary Concept]
- oenotheralanosterol B [MeSH Supplementary Concept]
- parkeol [MeSH Supplementary Concept]
- penasterol [MeSH Supplementary Concept]
- penasterone [MeSH Supplementary Concept]
- pneumocysterol [MeSH Supplementary Concept]
- polyporenic acid C [MeSH Supplementary Concept]
- tsugaric acid [MeSH Supplementary Concept]
- tsugarioside B [MeSH Supplementary Concept]
- tsugarioside C [MeSH Supplementary Concept]
- wallichinane D [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lanosterol [LOINC component]
- Lanosterol (substance) [SNOMED CT concept]
- lanosterol [Substance BNPC]
- lanosterol [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients